Bilaketaren emaitzak - G. N. Hortobágyi

  • Erakusten 1 - 11 emaitzak -- 11
Findu emaitzak
  1. 1
    Retrospective review of male breast cancer patients: analysis of tamoxifen-related side-effects

    Retrospective review of male breast cancer patients: analysis of tamoxifen-related side-effects nork Naveen Pemmaraju, Mark F. Munsell, G. N. Hortobagyi, Sharon H. Giordano

    Argitaratua 2011
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Lower dose capecitabine has a more favorable therapeutic index in metastatic breast cancer: retrospective analysis of patients treated at M. D. Anderson Cancer Center and a review of capecitabine toxicity in the literature

    Lower dose capecitabine has a more favorable therapeutic index in metastatic breast cancer: retrospective analysis of patients treated at M. D. Anderson Cancer Center and a review... nork Bryan T. Hennessy, Alain Gauthier, Laura Boehnke Michaud, G. N. Hortobagyi, Vicente Valero

    Argitaratua 2005
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Risk of Cardiac Death After Adjuvant Radiotherapy for Breast Cancer

    Risk of Cardiac Death After Adjuvant Radiotherapy for Breast Cancer nork Sharon H. Giordano, Yong‐Fang Kuo, J. L. Freeman, Thomas A. Buchholz, G. N. Hortobágyi, James S. Goodwin

    Argitaratua 2005
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Impact of delayed neoadjuvant systemic chemotherapy on survival among breast cancer patients

    Impact of delayed neoadjuvant systemic chemotherapy on survival among breast cancer patients nork Mariana Chávez‐MacGregor, Xiudong Lei, Débora De Melo Gagliato, Vicente Valero, Carlos H. Bárcenas, G. N. Hortobágyi, Sharon H. Giordano

    Argitaratua 2019
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Survival among women with triple receptor-negative breast cancer and brain metastases

    Survival among women with triple receptor-negative breast cancer and brain metastases nork Shaheenah Dawood, Kristine Broglio, Francisco J. Esteva, Wei Yang, Shu‐Wan Kau, R. Islam, Constance T. Albarracin, T. Yu, M. Green, G. N. Hortobágyi, Ana M. González-Angulo

    Argitaratua 2009
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implications

    Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implications nork Neslihan Cabıoğlu, Ayşegül A. Şahin, Paolo Morandi, F. Meric-Bernstam, R. Islam, Lin Hui, C D Bucana, Ana M. González-Angulo, G. N. Hortobágyi, Massimo Cristofanilli

    Argitaratua 2009
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer

    Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer nork Neslihan Cabıoğlu, Yun Yun Gong, R. Islam, Kristine Broglio, Nour Sneige, Ayşegül A. Şahin, Ana M. González-Angulo, Paolo Morandi, C Bucana, G. N. Hortobágyi, Massimo Cristofanilli

    Argitaratua 2007
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Meta-analysis of stomatitis in clinical studies of everolimus: incidence and relationship with efficacy

    Meta-analysis of stomatitis in clinical studies of everolimus: incidence and relationship with efficacy nork Hope S. Rugo, G. N. Hortobágyi, James C. Yao, Marianne Pavel, Alain Ravaud, David Neal Franz, François Ringeisen, Jorge D. Gallo, Nicolas Rouyrre, Oezlem Anak, Robert J. Motzer

    Argitaratua 2016
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  9. 9
    DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight

    DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight nork Daniel J. Weisenberger, Binh N. Trinh, Mihaela Campan, Sweta Sharma Saha, Tiffany I. Long, Suchitra Ananthnarayan, Gangning Liang, Francisco J. Esteva, G. N. Hortobagyi, F. McCormick, Peter A. Jones, Peter W. Laird

    Argitaratua 2008
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2

    Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2 nork Hope S. Rugo, Kathleen I. Pritchard, Michael Gnant, Shinzaburo Noguchi, Martine Piccart, G. N. Hortobagyi, José Baselga, Alejandra Perez, Matthias Geberth, Tibor Csőszi, E. Chouinard, Vichien Srimuninnimit, Puttisak Puttawibul, Janice F. Eakle, Wentao Feng, H. Bauly, Mona El-Hashimy, T Taran, Howard A. Burris

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    LBA17 Overall survival (OS) results from the phase III MONALEESA-2 (ML-2) trial of postmenopausal patients (pts) with hormone receptor positive/human epidermal growth factor receptor 2 negative (HR+/HER2−) advanced breast cancer (ABC) treated with endocrine therapy (ET) ± ribociclib (RIB)

    LBA17 Overall survival (OS) results from the phase III MONALEESA-2 (ML-2) trial of postmenopausal patients (pts) with hormone receptor positive/human epidermal growth factor recept... nork G. N. Hortobágyi, Salomon M. Stemmer, H.A. Burris, Yoon Sim Yap, Gabe S. Sonke, L. Hart, M. Campone, Katarína Petráková, Eric P. Winer, W Janni, Pierfranco Conté, David Cameron, Fabrice André, CL Arteaga, Juan Pablo Zarate, A. Chakravartty, Tanya Taran, Fabienne Le Gac, Patrizia Serra, Joyce O’Shaughnessy

    Argitaratua 2021
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: